WASHINGTON, Dec 3 (Reuters) - Orexigen Therapeutics's <OREX.O> diet drug, the last of a trio of fat pills to face scrutiny this year, appears to help some people lose weight but heart risks and other ...
SAN DIEGO, Nov. 25, 2013 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced successful results of the interim analysis of the Light Study. Based on these results, the Company ...
FDA Division of Metabolic and Endocrine Drug Products Advisory Committee Meeting Tentatively Scheduled to Review Contrave on December 7, 2010 SAN DIEGO, June 23, 2010 /PRNewswire via COMTEX/ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback